Dr. Reddy's Laboratories Limited (RDDA) — Cash Flow Reinvestment Rate
Dr. Reddy's Laboratories Limited (RDDA) has a Cash Flow Reinvestment Rate of 0.99x as of December 2025, reinvesting €10.80 Billion (capex €7.32 Billion plus investments €-3.48 Billion) from operating cash flow of €10.91 Billion. See how much free cash does Dr. Reddy's Laboratories Limited generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Dr. Reddy's Laboratories Limited Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Dr. Reddy's Laboratories Limited across 9 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Dr. Reddy's Laboratories Limited.
Annual Cash Flow Reinvestment Rate for Dr. Reddy's Laboratories Limited (2017–2025)
Year-by-year capital reinvestment analysis for Dr. Reddy's Laboratories Limited. See financial flexibility index of Dr. Reddy's Laboratories Limited to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.28x | €59.52 Billion | €46.43 Billion | €34.40 Billion | ▼ -14.0% |
| 2024 | 1.49x | €67.72 Billion | €45.43 Billion | €27.43 Billion | ▲ +45.7% |
| 2023 | 1.02x | €60.24 Billion | €58.88 Billion | €18.87 Billion | ▲ +11.2% |
| 2022 | 0.92x | €25.86 Billion | €28.11 Billion | €14.66 Billion | ▲ +137.2% |
| 2021 | 0.39x | €13.85 Billion | €35.70 Billion | €9.74 Billion | ▲ +128.8% |
| 2020 | 0.17x | €5.06 Billion | €29.84 Billion | €4.85 Billion | ▼ -47.3% |
| 2019 | 0.32x | €9.24 Billion | €28.70 Billion | €6.96 Billion | ▼ -57.6% |
| 2018 | 0.76x | €13.68 Billion | €18.03 Billion | €9.29 Billion | ▼ -52.2% |
| 2017 | 1.59x | €34.14 Billion | €21.51 Billion | €12.28 Billion | — |